Cleared Abbreviated

K011540 - VIEWPOINT CENTRAL MONITORING SYSTEM

K011540 is the FDA 510(k) clearance for VIEWPOINT CENTRAL MONITORING SYSTEM by Datascope Corp.. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Abbreviated 510(k) pathway after a 264-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2002
Decision
264d
Days
Class 2
Risk

K011540 is an FDA 510(k) clearance for the VIEWPOINT CENTRAL MONITORING SYSTEM, MODEL 0998-00-0187-07. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Datascope Corp. (Mahwh, US). The FDA issued a Cleared decision on February 6, 2002 after a review of 264 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Datascope Corp. devices

Submission Details

510(k) Number K011540 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 2001
Decision Date February 06, 2002
Days to Decision 264 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 125d · This submission: 264d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 256
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K011540.
DINAMAP PRO 1000 MONITOR, MODEL 1000
K012915 · Ge Medical Systems Information Technologies · Mar 2002
PHILIPS MULTI-PARAMETER MODULE, MODEL M3001A
K020531 · Philips Medical Systems · Mar 2002
ST/AR ST AND ARRHYTHMIA SOFTWARE, MODEL RELEASE E.0
K014261 · Philips Medical Systems, Inc. · Feb 2002
KION ANAESTHESIA SYSTEM, MODEL 65 03 879 E392E
K010923 · Siemens Elema AB · Jan 2002
SIEMENS INFINITY GATEWAY SUITE
K014213 · Siemens Medical Solutions USA, Inc. · Jan 2002
MODIFICATION TO:PHILIPS M3000A/M3046A COMPACT PORTABLE PATIENT MONITOR, MODELS PHILIPS M3000A/M3046A
K013427 · Philips Medical Systems, Inc. · Nov 2001